| Agribusiness | Technology | Type Of Deal | Amount | Terms (Date Announced) |
| Company | Partner | |||
| Novartis AG | None | Investment in new facility | $600M | 10 years; $55M/year plus $50M |
| (Novartis Agricultural | construction (7/98) | |||
| Discovery Institute) | ||||
| Hoechst Schering | Gene Logic Inc. | Research collaboration | $45M | 3 years; also milestones, royalties |
| AgrEvo GmbH | (7/98) | |||
| DuPont Agricul- | CuraGen Corp. | Research collaboration | ND | Contract research fees (7/98) |
| tural Enterprise | ||||
| (unit of DuPont Co.) | ||||
| Zeneca Agro- | Alanex Corp. (sub- | Zeneca to screen | ND | 3 years; license fees (6/98) |
| chemicals (divi- | sidiary of Agouron | Alanex library | ||
| sion of Zeneca Ltd.) | Pharmaceuticals Inc.) | |||
| Xyris Inc. | Axys | Start-up (Xyris) | $10M | Axys has 50% stake and will |
| Pharmaceuticals | (from Bay | provide administration, receive | ||
| Inc. | City Capital) | fees (5/98) | ||
| Monsanto Co. | Incyte | "Broad" access to gene | ND | 3 years (5/98) |
| Pharmaceuticals | expression technology | |||
| Inc. | ||||
| GeneTrace | Option to license | $17M | Equity, research funding, | |
| Systems Inc. | technology | supplies, license fees (4/98) | ||
| Millennium | Technology transfer | $218M | 5 years; $38M up front plus | |
| Pharmaceuticals | plus assistance to set | $16M/year technology transfer | ||
| Inc. | up MTC subsidiary | fee and $20M/year in milestones | ||
| (Cereon Genomics) | (10/97) | |||
| DuPont Agricul- | Pioneer Hi-Bred | Research alliance and | $1.7B | 20% equity stake in Pioneer; 50/50 |
| tural Enterprise | International Inc. | joint venture (Optimum | joint venture (9/97) | |
| (unit of DuPont Co.) | Quality Grains) | |||
